» Articles » PMID: 24014582

Progressive External Ophthalmoplegia (PEO) Due to a Mutation in the C10orf2 (PEO1) Gene Mimicking a Myasthenic Crisis

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2013 Sep 10
PMID 24014582
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We described a case of a patient with autosomal dominant progressive external ophthalmoplegia (PEO) who presented with the acute onset dysphagia, quadriparesis, ptosis and respiratory insufficiency following a cardiac procedure and mimicking a myasthenic crisis. A pathogenic mutation in the C10orf2 (PEO1) gene was confirmed. The unusual presentation of our patient contributes to expand the clinical phenotype of PEO1 mutations and reinforces the need to consider mitochondrial myopathy as differential diagnosis of myasthenia gravis even in the case of acute onset symptoms.

Citing Articles

Have one's view of the important overshadowed by the trivial: chronic progressive external ophthalmoplegia combined with unilateral facial nerve injury: a case report and literature review.

Feng Z, Lai R, Wei J, Liu X, Chen X, Liu Y Front Neurol. 2024; 14:1268053.

PMID: 38249737 PMC: 10797034. DOI: 10.3389/fneur.2023.1268053.


Gastrointestinal manifestations of mitochondrial disorders: a systematic review.

Finsterer J, Frank M Therap Adv Gastroenterol. 2017; 10(1):142-154.

PMID: 28286566 PMC: 5330602. DOI: 10.1177/1756283X16666806.


Progressive External Ophthalmoplegia.

McClelland C, Manousakis G, Lee M Curr Neurol Neurosci Rep. 2016; 16(6):53.

PMID: 27072953 DOI: 10.1007/s11910-016-0652-7.

References
1.
Bohlega S, van Goethem G, Al Semari A, Lofgren A, Al Hamed M, Van Broeckhoven C . Novel Twinkle gene mutation in autosomal dominant progressive external ophthalmoplegia and multisystem failure. Neuromuscul Disord. 2009; 19(12):845-8. DOI: 10.1016/j.nmd.2009.10.002. View

2.
Kauffman M, Gonzlez-Moron D, Consalvo D, Westergaard G, Vazquez M, Mancini E . Diagnosis of mitochondrial disorders applying massive pyrosequencing. Mol Biol Rep. 2012; 39(6):6655-60. DOI: 10.1007/s11033-012-1471-9. View

3.
Lopez-Gallardo E, Lopez-Perez M, Montoya J, Ruiz-Pesini E . CPEO and KSS differ in the percentage and location of the mtDNA deletion. Mitochondrion. 2009; 9(5):314-7. DOI: 10.1016/j.mito.2009.04.005. View

4.
Finsterer J, Segall L . Drugs interfering with mitochondrial disorders. Drug Chem Toxicol. 2009; 33(2):138-51. DOI: 10.3109/01480540903207076. View

5.
Virgilio R, Ronchi D, Hadjigeorgiou G, Bordoni A, Saladino F, Moggio M . Novel Twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia. J Neurol. 2008; 255(9):1384-91. DOI: 10.1007/s00415-008-0926-3. View